Inventor · disambiguated record
Jincong Zhuo
Also filed as: ZHUO JINCONG
76 granted patents·26 pending applications·1,143 citations·filing 2004–2025
99Inventor score
Top patents by PatentIndex Score
102 records- 0199US8691807B2Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitorsYAO WENQING·Filed 2012·Granted Apr 8, 2014·114 cites·44 claims
- 0299US7767675B2Imidazotriazines and imidazopyrimidines as kinase inhibitorsINCYTE CORP·Filed 2007·Granted Aug 3, 2010·85 cites·85 claims
- 0398US10813930B2Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3INCYTE CORP·Filed 2019·Granted Oct 27, 2020·27 cites·42 claims
- 0498US10435392B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2018·Granted Oct 8, 2019·18 cites·28 claims
- 0598US10213427B2Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3INCYTE CORP·Filed 2016·Granted Feb 26, 2019·34 cites·39 claims
- 0698US9611269B2Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitorsINCYTE CORP·Filed 2015·Granted Apr 4, 2017·45 cites·24 claims
- 0798US9533984B2Bicyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2014·Granted Jan 3, 2017·42 cites·6 claims
- 0898US9266892B2Fused pyrazoles as FGFR inhibitorsINCYTE CORP·Filed 2013·Granted Feb 23, 2016·40 cites·40 claims
- 0998US9023840B2Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitorsINCYTE CORP·Filed 2014·Granted May 5, 2015·64 cites·21 claims
- 1097US11591318B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2021·Granted Feb 28, 2023·6 cites·19 claims
- 1197US11001571B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2019·Granted May 11, 2021·15 cites·16 claims
- 1297US10513522B2Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitorsINCYTE CORP·Filed 2017·Granted Dec 24, 2019·20 cites·25 claims
- 1397US9540347B2Pyridineamine compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Jan 10, 2017·19 cites·70 claims
- 1497US9533954B2Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3INCYTE CORP·Filed 2014·Granted Jan 3, 2017·42 cites·26 claims
- 1597US9382231B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2014·Granted Jul 5, 2016·40 cites·30 claims
- 1697US8754114B2Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3YAO WENQING·Filed 2011·Granted Jun 17, 2014·49 cites·26 claims
- 1797US8461330B2Imidazotriazines and imidazopyrimidines as kinase inhibitorsZHUO JINCONG·Filed 2010·Granted Jun 11, 2013·40 cites·25 claims
- 1896US11214573B2Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitorsINCYTE CORP·Filed 2019·Granted Jan 4, 2022·14 cites·23 claims
- 1996US9988387B2Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitorsINCYTE HOLDINGS CORP·Filed 2015·Granted Jun 5, 2018·9 cites·12 claims
- 2096US9926301B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2016·Granted Mar 27, 2018·18 cites·37 claims
- 2196US9802918B2Pyridineamine compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Oct 31, 2017·13 cites·16 claims
- 2296US9221824B2Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitorsINCYTE CORP·Filed 2013·Granted Dec 29, 2015·14 cites·5 claims
- 2396US8487096B2Imidazo[1,2-B][1,2,4]triazines as C-MET inhibitorsZHUO JINCONG·Filed 2011·Granted Jul 16, 2013·15 cites·8 claims
- 2496US7776874B2Amido compounds and their use as pharmaceuticalsINCYTE CORP·Filed 2008·Granted Aug 17, 2010·27 cites·24 claims
- 2596US7304081B2Amido compounds and their use as pharmaceuticalsINCYTE CORP·Filed 2005·Granted Dec 4, 2007·42 cites·25 claims
- 2695US11905275B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2023·Granted Feb 20, 2024·2 cites·29 claims
- 2795US9944645B2Imidazotriazines and imidazopyrimidines as kinase inhibitorsINCYTE HOLDINGS CORP·Filed 2016·Granted Apr 17, 2018·15 cites·15 claims
- 2895US9695180B2Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2015·Granted Jul 4, 2017·24 cites·53 claims
- 2995US8058288B2Amido compounds and their use as pharmaceuticalsYAO WENQING·Filed 2010·Granted Nov 15, 2011·22 cites·35 claims
- 3094US10472367B2Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitorsINCYTE HOLDINGS CORP·Filed 2018·Granted Nov 12, 2019·5 cites·18 claims
- 3194US10112950B2Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2017·Granted Oct 30, 2018·15 cites·58 claims
- 3294US9126927B2Amido compounds and their use as pharmaceuticalsYAO WENQING·Filed 2011·Granted Sep 8, 2015·20 cites·33 claims
- 3394US7683060B2Triazolotriazines as kinase inhibitorsINCYTE CORP·Filed 2007·Granted Mar 23, 2010·25 cites·152 claims
- 3493US9920032B2Heterocyclic compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Mar 20, 2018·12 cites·31 claims
- 3593US8071624B2N-substituted piperidines and their use as pharmaceuticalsYAO WENQING·Filed 2005·Granted Dec 6, 2011·26 cites·43 claims
- 3692US10738052B2Imidazotriaines and imidazopyrimidines as kinase inhibitorsINCYTE CORP·Filed 2018·Granted Aug 11, 2020·3 cites·18 claims
- 3792US9801877B2AZA spiro alkane derivatives as inhibitors of metalloproteasesINCYTE CORP·Filed 2016·Granted Oct 31, 2017·7 cites·18 claims
- 3892US7687665B22-methylprop anamides and their use as pharmaceuticalsINCYTE CORP·Filed 2005·Granted Mar 30, 2010·24 cites·28 claims
- 3990US10556908B2Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2018·Granted Feb 11, 2020·8 cites·37 claims
- 4089US9957229B2Amido compounds and their use as pharmaceuticalsINCYTE CORP·Filed 2017·Granted May 1, 2018·4 cites·6 claims
- 4189US7723349B2Aza spiro alkane derivatives as inhibitors of metalloproteasesINCYTE CORP·Filed 2004·Granted May 25, 2010·21 cites·15 claims
- 4289US2025223291A1Imidazotriazines and imidazopyrimidines as kinase inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 4388US10450296B2Heterocyclic compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2018·Granted Oct 22, 2019·6 cites·25 claims
- 4487US12247020B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2024·Granted Mar 11, 2025·0 cites·20 claims
- 4587US11939340B2CDK inhibitors and their use as pharmaceuticalsPRELUDE THERAPEUTICS INC·Filed 2023·Granted Mar 26, 2024·1 cites·24 claims
- 4686US8039471B2Aza spiro alkane derivatives as inhibitors of metalloproteasesINCYTE CORP·Filed 2008·Granted Oct 18, 2011·5 cites·17 claims
- 4785US10919901B2Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitorsINCYTE HOLDINGS CORP·Filed 2019·Granted Feb 16, 2021·1 cites·12 claims
- 4885US8143251B2Triazolotriazines as kinase inhibitorsZHUO JINCONG·Filed 2011·Granted Mar 27, 2012·7 cites·17 claims
- 4984US7915408B2Triazolotriazines as kinase inhibitorsINCYTE CORP·Filed 2010·Granted Mar 29, 2011·6 cites·29 claims
- 5083US8637497B2AZA spiro alkane derivatives as inhibitors of metalloproteasesYAO WENQING·Filed 2011·Granted Jan 28, 2014·4 cites·10 claims
Showing the top 50 of 102 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jincong Zhuo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →